Morgan Brown
Vermögen: - $ am 30.09.2026
Vermögen: - $ am 30.09.2026
Morgan R.
Brown is currently Chief Financial Officer at Clene Nanomedicine, Inc. and Clene, Inc., both positions starting in 2022.
Former roles include Chief Financial Officer & Executive Vice President at Lipocine, Inc. from 2013 to 2022; Chief Financial Officer & Executive Vice President at Innovus Pharmaceuticals, Inc. in 2013; CEO, Secretary & Head-Investor Relations at World Heart Corp.
in 2012; Chief Financial Officer & Senior Vice President at Lifetree Clinical Research LC from 2008 to 2009; Treasurer & Vice President-Finance at NPS Pharmaceuticals, Inc. from 2000 to 2008; Senior Manager-Audit at KPMG LLP from 1993 to 2000; and membership in The American Institute of Certified Public Accountants and Utah Association of Certified Public Accountants.
Education includes an MBA from the University of Utah and an undergraduate degree from Utah State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CLENE INC -.--% | 20.10.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CLENE INC. | Finanzdirektor/CFO | 01.02.2022 |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Finanzdirektor/CFO | 01.02.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| LIPOCINE INC. | Finanzdirektor/CFO | 31.01.2022 |
| INNOVUS PHARMACEUTICALS INC | Finanzdirektor/CFO | 01.09.2013 |
World Heart Corp.
World Heart Corp. Miscellaneous Commercial ServicesCommercial Services Develops artificial heart and related technologies | Vorstandsvorsitzender | 01.08.2012 |
Lifetree Clinical Research LC
Lifetree Clinical Research LC Miscellaneous Commercial ServicesCommercial Services Provides clinical research | Finanzdirektor/CFO | 01.08.2009 |
| NPS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.01.2008 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
World Heart Corp.
World Heart Corp. Miscellaneous Commercial ServicesCommercial Services Develops artificial heart and related technologies | Commercial Services |
Innovus Pharmaceuticals, Inc.
Innovus Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Engages in commercialization, licensing and development of medicine and consumer care products | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Utah State University
Utah State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Utah Association of Certified Public Accountants | |
Lifetree Clinical Research LC
Lifetree Clinical Research LC Miscellaneous Commercial ServicesCommercial Services Provides clinical research | Commercial Services |
Lipocine, Inc.
Lipocine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research and development for the delivery of drugs | Health Technology |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Health Technology |
Clene, Inc.
Clene, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen